
Maintaining business continuity during COVID-19
Lessons learned will have positive impacts beyond the pandemic

A roundup of COVID-19 treatments in development
How COVID-19 is accelerating cell therapy innovation

Being an NMDP/Be The Match courier during COVID-19
Making essential treatments possible in the midst of a pandemic

Overcoming autologous cell therapy logistics challenges in the age of COVID-19
Experienced team for managed logistics is key

Can cell therapies unlock the COVID-19 mystery?
The promise of MSC therapies to treat deadly manifestations of cytokine storms

How COVID-19 is changing the production of cell therapies
Implementation of contingency plans allows for continued progress in therapy development

Managing donor collections during the COVID-19 pandemic
Why a diverse apheresis center network is critical to business continuity

Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)
Why established systems and relationships matter